These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 10844707)
21. Assessment of cognitive impairment: relationship of the Dementia Rating Scale to the Mini-Mental State Examination. Bobholz JH; Brandt J J Geriatr Psychiatry Neurol; 1993; 6(4):210-3. PubMed ID: 8251048 [TBL] [Abstract][Full Text] [Related]
22. Cognitive decline and survival in Alzheimer's disease according to education level. Bruandet A; Richard F; Bombois S; Maurage CA; Masse I; Amouyel P; Pasquier F Dement Geriatr Cogn Disord; 2008; 25(1):74-80. PubMed ID: 18042993 [TBL] [Abstract][Full Text] [Related]
23. Dementia with Lewy bodies is associated with higher scores on the Geriatric Depression Scale than is Alzheimer's disease. Yamane Y; Sakai K; Maeda K Psychogeriatrics; 2011 Sep; 11(3):157-65. PubMed ID: 21951956 [TBL] [Abstract][Full Text] [Related]
24. Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests. Palmqvist S; Hansson O; Minthon L; Londos E Int J Geriatr Psychiatry; 2009 Dec; 24(12):1405-12. PubMed ID: 19347836 [TBL] [Abstract][Full Text] [Related]
25. Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods. Teipel SJ; Mitchell AJ; Möller HJ; Hampel H J Neural Transm Suppl; 2007; (72):241-7. PubMed ID: 17982900 [TBL] [Abstract][Full Text] [Related]
26. Modelling mini mental state examination changes in Alzheimer's disease. Mendiondo MS; Ashford JW; Kryscio RJ; Schmitt FA Stat Med; 2000 Jun 15-30; 19(11-12):1607-16. PubMed ID: 10844722 [TBL] [Abstract][Full Text] [Related]
27. An investigation of the efficiency of the mini-Kingston standardized cognitive assessment-revised in classifying patients according to DSM-5 major and mild neurocognitive disorders due to possible Alzheimer's disease. Heinik J; Kavé G Int Psychogeriatr; 2015 May; 27(5):785-91. PubMed ID: 25597552 [TBL] [Abstract][Full Text] [Related]
28. Assessing cognitive changes in the elderly: reliable change indices for the Mini-Mental State Examination. Stein J; Luppa M; Maier W; Wagner M; Wolfsgruber S; Scherer M; Köhler M; Eisele M; Weyerer S; Werle J; Bickel H; Mösch E; Wiese B; Prokein J; Pentzek M; Fuchs A; Leicht H; König HH; Riedel-Heller SG; Acta Psychiatr Scand; 2012 Sep; 126(3):208-18. PubMed ID: 22375927 [TBL] [Abstract][Full Text] [Related]
29. The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts. Cano SJ; Posner HB; Moline ML; Hurt SW; Swartz J; Hsu T; Hobart JC J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1363-8. PubMed ID: 20881017 [TBL] [Abstract][Full Text] [Related]
30. Validation of a French version of an informant-based questionnaire as a screening test for Alzheimer's disease. Law S; Wolfson C Br J Psychiatry; 1995 Oct; 167(4):541-4. PubMed ID: 8829727 [TBL] [Abstract][Full Text] [Related]
31. Longitudinal trajectories of cognitive change in preclinical Alzheimer's disease: a growth mixture modeling analysis. Small BJ; Bäckman L Cortex; 2007 Oct; 43(7):826-34. PubMed ID: 17941341 [TBL] [Abstract][Full Text] [Related]
32. High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies. Cagnin A; Bussè C; Jelcic N; Gnoato F; Mitolo M; Caffarra P Parkinsonism Relat Disord; 2015 Mar; 21(3):303-5. PubMed ID: 25547859 [TBL] [Abstract][Full Text] [Related]
33. Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease. Mohs RC; Schmeidler J; Aryan M Stat Med; 2000 Jun 15-30; 19(11-12):1401-9. PubMed ID: 10844705 [TBL] [Abstract][Full Text] [Related]
34. MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. Biundo R; Weis L; Bostantjopoulou S; Stefanova E; Falup-Pecurariu C; Kramberger MG; Geurtsen GJ; Antonini A; Weintraub D; Aarsland D J Neural Transm (Vienna); 2016 Apr; 123(4):431-8. PubMed ID: 26852137 [TBL] [Abstract][Full Text] [Related]
35. Cognitive decline in Alzheimer's disease: elaborating on the nature of the longitudinal factor structure of the Mini-Mental State Examination. Brooks JO; Yesavage JA; Taylor J; Friedman L; Tanke ED; Luby V; Tinklenberg J Int Psychogeriatr; 1993; 5(2):135-46. PubMed ID: 8292767 [TBL] [Abstract][Full Text] [Related]
36. A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors. Lucchi E; Minicuci N; Magnifico F; Mondini S; Calza A; Avanzi S; Villani D; Bellelli G; Trabucchi M Arch Gerontol Geriatr Suppl; 2004; (9):253-63. PubMed ID: 15207422 [TBL] [Abstract][Full Text] [Related]
37. Cohort Effects in Progression Rate on Cognitive and Functional Measures in an Alzheimer's Disease Clinical Cohort. Pavlik VN; Chan W; Darby E J Alzheimers Dis; 2019; 71(2):659-669. PubMed ID: 31424408 [TBL] [Abstract][Full Text] [Related]
39. Predictors of decline in Alzheimer's disease. Boller F; Becker JT; Holland AL; Forbes MM; Hood PC; McGonigle-Gibson KL Cortex; 1991 Mar; 27(1):9-17. PubMed ID: 2055046 [TBL] [Abstract][Full Text] [Related]
40. Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan. Wang CS; Pai MC; Chen PL; Hou NT; Chien PF; Huang YC Int Psychogeriatr; 2013 Nov; 25(11):1839-48. PubMed ID: 23919950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]